Education
About Us
Working with TipRanks
Follow Us
GRPZ - ETF AI Analysis
Top Page
Invesco S&P SmallCap 600 GARP ETF (GRPZ)
Rating:74Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, like InterDigital and Sterling Infrastructure, have delivered strong year-to-date gains, supporting the fund's performance.
Sector Diversification
The ETF spreads its investments across multiple sectors, including Industrials, Consumer Cyclical, and Technology, reducing reliance on any single industry.
Reasonable Expense Ratio
The fund's expense ratio of 0.35% is competitive for a specialized ETF, helping investors keep more of their returns.
Negative Factors
High Geographic Concentration
With nearly 100% exposure to U.S. companies, the fund lacks diversification across global markets.
Mixed Performance in Top Holdings
Some key holdings, like Worthington Steel and Helmerich & Payne, have underperformed year-to-date, creating drag on overall returns.
Small Asset Base
The ETF has relatively low assets under management, which could lead to less liquidity and higher trading costs for investors.
GRPZ vs. SPDR S&P 500 ETF (SPY)
AUM2.75M
RegionNorth America
Expense Ratio0.35%
Beta0.96
IssuerInvesco
Inception DateMar 27, 2024
Dividend Yield0.94%
Asset ClassEquity
Index TrackedS&P SmallCap 600 GARP Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume406
30 Day Avg. Volume257
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.39Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering91
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GRPZ Summary
The Invesco S&P SmallCap 600 GARP ETF (GRPZ) is an investment fund that focuses on small U.S. companies with strong growth potential and reasonable valuations. It tracks the S&P SmallCap 600 GARP Index, which includes businesses across various industries like technology, healthcare, and energy. Some of its top holdings include Powell Industries and InterDigital. This ETF could be a good choice for investors looking to diversify their portfolio and benefit from the growth opportunities in smaller, agile companies. However, new investors should know that small-cap stocks can be more volatile and may experience larger price swings than larger, established companies.
How much will it cost me?The Invesco S&P SmallCap 600 GARP ETF (GRPZ) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it tracks a specific index with a focus on small-cap companies and uses a more selective strategy. It’s still relatively affordable compared to actively managed funds.
What would affect this ETF?GRPZ could benefit from economic growth in the U.S., as small-cap companies often thrive during periods of expansion and innovation, particularly in sectors like Industrials and Technology, which are heavily weighted in the ETF. However, rising interest rates or economic slowdowns could negatively impact small-cap stocks, as these companies may face higher borrowing costs and reduced consumer demand, especially in sectors like Consumer Cyclical and Financials. Regulatory changes or shifts in energy policies could also affect holdings like Helmerich & Payne and International Seaways in the Energy sector.
GRPZ Top 10 Holdings
The Invesco S&P SmallCap 600 GARP ETF (GRPZ) is leaning heavily into U.S. small-cap stocks, with a notable focus on industrials, consumer cyclical, and healthcare sectors. Powell Industries and Krystal Biotech are rising stars, driving performance with strong financials and strategic growth. Dycom is another standout, benefiting from acquisitions and revenue guidance boosts. On the flip side, Helmerich & Payne is lagging due to profitability challenges, while International Seaways struggles with revenue declines. The fund’s sector diversity provides balance, but its reliance on a few high-performing names underscores its concentrated approach.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Catalyst Pharma | 1.83% | $50.14K | $2.99B | 13.41% | 83 Outperform | |
| Krystal Biotech | 1.76% | $48.42K | $7.31B | 58.31% | 80 Outperform | |
| Ufp Technologies | 1.69% | $46.50K | $1.83B | -3.96% | 75 Outperform | |
| International Seaways | 1.66% | $45.68K | $2.40B | 35.62% | 72 Outperform | |
| ADMA Biologics | 1.65% | $45.35K | $4.59B | 10.49% | 78 Outperform | |
| Cal-Maine Foods | 1.64% | $44.93K | $3.98B | -18.94% | 84 Outperform | |
| TG Therapeutics | 1.63% | $44.71K | $4.89B | -5.41% | 65 Neutral | |
| Palomar Holdings | 1.57% | $43.13K | $3.57B | 29.11% | 83 Outperform | |
| Axos Financial | 1.57% | $43.12K | $4.99B | 23.68% | 78 Outperform | |
| TransMedics Group | 1.57% | $43.10K | $4.24B | 103.54% | 77 Outperform |
GRPZ Technical Analysis
Positive
―
Price Trends
26.58
Positive
26.56
Positive
25.21
Positive
Market Momentum
0.29
Positive
57.55
Neutral
11.15
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GRPZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.32, equal to the 50-day MA of 26.58, and equal to the 200-day MA of 25.21, indicating a bullish trend. The MACD of 0.29 indicates Positive momentum. The RSI at 57.55 is Neutral, neither overbought nor oversold. The STOCH value of 11.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GRPZ.
GRPZ Peer Comparison
Comparison Results
Performance Comparison
GRPZ
Invesco S&P SmallCap 600 GARP ETF
27.44
1.74
6.77%
FLQS
Franklin LibertyQ U.S. Small Cap Equity ETF
―
―
―
AFSM
First Trust Active Factor Small Cap ETF
―
―
―
STXK
Strive 2000 ETF
―
―
―
FSCC
Federated Hermes MDT Small Cap Core ETF
―
―
―
BKSE
BNY Mellon US Small Cap Core Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents